Baxter International signed a euro1.5 billion ($1.36 billion) MTN programme on February 15 2001, with an expected initial series of notes to total euro500 million. Credit Suisse First Boston has won the arrangership. This is Baxter's first MTN programme. The borrower issued a euro600 million CP programme in November 2000, with UBS Warburg as the arranger. The programme has euro293 million outstanding off 11 issues. The MTN programme is rated A from both Standard & Poor's and Fitch, whilst Moody's give A3. The latter gives the programme a negative outlook, with the two former rating agencies say the outlook is stable. Based in the US, Baxter's market is healthcare, pharmaceuticals and biotechnology. Baxter maintains significant operations in Europe with approximately 26% of sales originating there. The dealers are the arranger, Deutsche Bank, JP Morgan, Salomon Smith Barney, and UBS Warburg.
February 23, 2001